A phase I trial investigating the pharmacokinetics of OX 27 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2012
At a glance
- Drugs Sufentanil (Primary)
- Indications Cancer pain
- Focus Pharmacokinetics
- 25 Oct 2011 New source identified (European Clinical Trials Database record).
- 14 Jun 2011 Pharmacokinetic outcomes were reported in an Orexo media release.
- 01 Jun 2011 Status changed from not stated to completed.